Vida Ventures

Vida Ventures accounts for 25 tracked companies with verified cap-table data, 25 of which disclose round sizes totalling $4.6B. The median disclosed raise is $165M, and the largest is ReCode Therapeutics at $570M, ahead of Cullinan Oncology ($499M) and Hexagon Bio ($323M).

The names that recur most often on these co-invested cap tables are Vida Ventures (25 companies), Polaris Partners (7 companies), OrbiMed (5 companies), The Column Group (4 companies), Nextech Invest (4 companies), Omega Funds (4 companies). By latest disclosed round, the market skews Series A (10), Series B (4), Series C (4), Seed (3).

• Companies tracked: 25
• Disclosed funding total: $4.6B across 25 companies
• Median disclosed raise: $165M
• Largest raise: ReCode Therapeutics — $570M
• Stage mix: Series A 10 · Series B 4 · Series C 4 · Seed 3
• Most recent dated round: 2026-03-01

Best funded Vida Ventures companies

1. ReCode Therapeutics — $570M (latest: Series B)
2. Cullinan Oncology — $499M (latest: IPO)
3. Hexagon Bio — $323M (latest: Series B)
4. Asklepios BioPharmaceutical — $235M (latest: Growth)
5. Alterome Therapeutics — $231M (latest: Series A)
6. Soufflé Therapeutics — $200M (latest: Series A)
7. PACT Pharma — $200M (latest: Series C)
8. Dyne Therapeutics — $200M (latest: Series E)
9. Kinnate Biopharma — $195M (latest: Series C)
10. Protego Biopharma — $181M (latest: Series B)
11. Antares Therapeutics — $177M (latest: Series A)
12. Affini-T Therapeutics — $175M (latest: Seed)
13. Capstan Therapeutics — $165M (latest: Series A)
14. Third Arc Bio — $165M (latest: Series A)
15. Quanta Therapeutics — $142M (latest: Series D)

Vida Ventures — related firms and companies (56)

• ReCode Therapeutics
• Cullinan Oncology
• Hexagon Bio
• Asklepios BioPharmaceutical
• Alterome Therapeutics
• Soufflé Therapeutics
• PACT Pharma
• Dyne Therapeutics
• Investors like Insight Partners
• A2 Biotherapeutics
• Investors like 500 Global
• Investors like Trinity Ventures
• Investors like Vida Ventures
• Investors like Bienville Capital
• LB Pharmaceuticals
• Investors like First Round Capital
• Investors like N47
• Companies backed by Vida Ventures
• Investors like Ventioneers
• Kronos Bio
• Investors like Blockchain Capital
• Investors like Contour Venture Partners
• Founders backed by Vida Ventures
• Investors like Shasta Ventures
• Praxis Precision Medicines
• Investors like 137 Ventures
• Kinnate Biopharma
• Investors like Casdin Capital
• Investors like Emergence Capital
• Poplar Therapeutics
• Investors like StepStone Group
• Protego Biopharma
• Investors like Altos Ventures
• Investors like FirstMark
• InduPro
• Investors like F-Prime
• Antares Therapeutics
• Investors like Amino Capital
• Firms like GV
• Volastra Therapeutics
• Investors like Torch Capital
• Affini-T Therapeutics
• Investors like GSR Ventures
• Investors like Founder Collective
• Tectonic Therapeutic
• Investors like Maveron
• Capstan Therapeutics
• Investors like Western Technology Investment
• Investors like Bain Capital Ventures
• Pionyr Immunotherapeutics
• Investors like General Atlantic
• Third Arc Bio
• Investors like Scale Venture Partners
• Investors like Index Ventures
• IconOVir Bio
• Investors like Gaingels

Vida Ventures alternatives · All research reports